Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
analgesic |
| gptkbp:activeIngredient |
gptkb:paracetamol
caffeine propyphenazone |
| gptkbp:category |
non-opioid analgesic
analgesic combination |
| gptkbp:contains |
caffeine 50 mg
paracetamol 250 mg propyphenazone 150 mg |
| gptkbp:contraindication |
hypersensitivity to ingredients
renal impairment pregnancy (consult doctor) liver impairment |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Saridon
|
| gptkbp:launched |
1933
|
| gptkbp:legalStatus |
banned in some countries
approved in India |
| gptkbp:manufacturer |
gptkb:Piramal_Enterprises
gptkb:Roche |
| gptkbp:marketedIn |
gptkb:Germany
gptkb:India gptkb:Switzerland other countries |
| gptkbp:prescriptionStatus |
prescription-only (in some countries)
over-the-counter (in some countries) |
| gptkbp:sideEffect |
allergic reactions
gastrointestinal disturbances |
| gptkbp:usedFor |
headache
pain relief |
| gptkbp:bfsParent |
gptkb:Saridon_Ke_Saathi
|
| gptkbp:bfsLayer |
7
|